AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
SEATTLE--Proton-pump inhibitors, the therapeutic mainstay for gastroesophageal reflux disease, are also highly effective in the treatment of nonerosive reflux disease, according to a new metaanalysis.
That's good news, since nonerosive reflux disease (NERD) accounts for an estimated 50%-70% of total cases of gastroesophageal reflux disease (GERD). Prior to the metaanalysis, there wasn't really persuasive evidence that proton-pump inhibitors (PPIs) are effective in NERD. The great majority of data supporting PPI therapy in GERD come from clinical trials restricted to the minority of GERD patients having endoscopic evidence of erosive esophagitis, Dr. Ronnie Pass said at the annual meeting of the American College of Gastroenterology.
Indeed, after reviewing 107 studies on PPI therapy published or presented in ...
Source: HighBeam Research, Proton-pump inhibitors also effective in nonerosive reflux disease....